Should preclinical studies be registered?

Nature Biotechnology

Volumn 30, Issue 6, 2012, Pages 488-489

  Kimmelman, Jonathan ^a   Anderson, James A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL STUDY; GENE TRANSFER; GOOD CLINICAL PRACTICE; HUMAN; LAW; LETTER; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REGISTER; REGISTRATION;

ANIMALS; BIOMEDICAL RESEARCH; DISCLOSURE; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; HUMANS; RECORDS AS TOPIC; UNITED STATES;

EID: 84861998609     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2261     Document Type: Letter

References (11)

1. Laine, C. et al. Ann. Intern. Med. 147, 275-277 (2007).
2. Anonymous. Nat. Biotechnol. 30, 371 (2012).
3. Sena, E.S., van der Worp, H.B., Bath, P.M., Howells, D.W. & Macleod, M. PLoS Biol. 8, e1000344 (2010).
4. Kola, I. & Landis, J. Nat. Rev. Drug Discov. 3, 711-715 (2004).
5. Duhem, P.M.M. The Aim and Structure of Physical Theory (Princeton University Press, Princeton, NJ; 1954).
6. Bath, P.M. et al. Br. J. Pharmacol. 157, 1157-1171 (2009).
7. Lorente, J.A. & Marshall, J.C. Shock 24, 107-119 (2005).
8. Clarke, J. et al. Regul. Toxicol. Pharmacol. 50, 2-22 (2008).
9. Obach, R.S. et al. J. Pharmacol. Exp. Ther. 283, 46-58 (1997).
10. Ross, J.S. et al. Br. Med. J. 344, d7292 (2012).
11. Zarin, D.A. et al. J. Am. Med. Assoc. 297, 2112-2120 (2007).